Li K-L, Chen C-Y, Xu M, Zhu X-Q, Yang X-J
Department of Neurology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China.
Department of Internal Medicine, Shanghai Electric Power Hospital, Shanghai 200050, China.
Cell Mol Biol (Noisy-le-grand). 2017 Oct 31;63(10):137-140. doi: 10.14715/cmb/2017.63.10.22.
Some reports evaluated the association between ALOX5AP rs10507391 polymorphism and the risk of ischemic stroke in Caucasians. The results remained unknown. Thus, we did a meta-analysis to evaluate this association. Nine case-control studies with 4198 patients and 3699 controls were included in this meta-analysis. A significant association was found between ALOX5AP rs10507391 polymorphism and ischemic stroke risk in Caucasians (OR=1.18; 95%CI, 1.08-1.28; P=0.0002). ALOX5AP rs10507391 polymorphism was associated with ischemic stroke risk in Caucasians from Europe (OR=1.20; 95%CI, 1.09-1.32; P=0.0002) but not from other countries (OR=1.13; 95%CI, 0.95-1.36; P=0.17). No significant association was found between ALOX5AP rs10507391 polymorphism and ischemic stroke risk in males (OR=1.12; 95%CI, 0.91-1.39; P=0.28). Moreover, ALOX5AP rs10507391 polymorphism was not associated with cardioembolic ischemic stroke risk (OR=1.04; 95%CI, 0.73-1.48; P=0.84). In conclusion, this study found that ALOX5AP rs10507391 polymorphism was associated with ischemic stroke risk in Caucasians.
一些报告评估了白种人中5-脂氧合酶激活蛋白(ALOX5AP)基因rs10507391多态性与缺血性中风风险之间的关联。结果尚不清楚。因此,我们进行了一项荟萃分析来评估这种关联。该荟萃分析纳入了9项病例对照研究,共4198例患者和3699例对照。研究发现,白种人中ALOX5AP基因rs10507391多态性与缺血性中风风险之间存在显著关联(比值比[OR]=1.18;95%置信区间[CI]为1.08 - 1.28;P=0.0002)。ALOX5AP基因rs10507391多态性与欧洲白种人的缺血性中风风险相关(OR=1.20;95%CI为1.09 - 1.32;P=0.0002),但与其他国家白种人的缺血性中风风险无关(OR=1.13;95%CI为0.95 - 1.36;P=0.17)。在男性中,未发现ALOX5AP基因rs10507391多态性与缺血性中风风险之间存在显著关联(OR=1.12;95%CI为0.91 - 1.39;P=0.28)。此外,ALOX5AP基因rs10507391多态性与心源性栓塞性缺血性中风风险无关(OR=1.04;95%CI为0.73 - 1.48;P=0.84)。总之,本研究发现ALOX5AP基因rs10507391多态性与白种人的缺血性中风风险相关。